Serge Saxonov - 22 Nov 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Sale	$162,816	-3,757	-0.44%	$43.34	851,169	22 Nov 2023	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$162,751	-3,723	-0.44%	$43.72	847,446	24 Nov 2023	Direct	F2
holding	TXG	Class A Common Stock						27	22 Nov 2023	See footnote	F3
holding	TXG	Class A Common Stock						870	22 Nov 2023	See footnote	F4
holding	TXG	Class A Common Stock						183,350	22 Nov 2023	See footnote	F5
holding	TXG	Class A Common Stock						16,320	22 Nov 2023	See footnote	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2	This transaction was executed in multiple trades at prices ranging from $43.65 to $43.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3	The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F4	The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F5	The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F6	The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.